The Latest Breaking News from Ron Wyden

Democrats race to prep sweeping budget bill for weekend votes

WASHINGTON — The Senate is expected to begin consideration of Democrats’ climate, tax and health care package on Saturday, leaving about two days for the party to shore up support for the bill.

Tribune News Service · Aug 4, 2022

Changes mulled to sweeping budget package as debate nears

Democrats may need to make some changes to the tax portion of their budget reconciliation package to earn the support of Arizona Sen. Kyrsten Sinema, including possible removal of a tax increase on investment fund managers and softening a new minimum tax on the biggest corporations.

Tribune News Service · Aug 4, 2022

Changes mulled to sweeping budget package as debate nears

Democratic leaders in the Senate need to woo Arizona Sen. Kyrsten Sinema, but some don't want to give away too much

Roll Call · Aug 3, 2022

Halting backdoor government snooping seen as key to data privacy

WASHINGTON — As the House Energy and Commerce Committee approved a federal data privacy bill last week, lawmakers on the House Judiciary Committee were looking to plug a gap in the law that allows government agencies to conduct broad surveillance without obtaining warrants or subpoenas to do so.

Tribune News Service · Jul 27, 2022

Chuck Schumer Learned Nothing From the Failure of Pot Legalization in California

The Senate majority leader’s marijuana bill would pile on more taxes and regulations, despite years of complaints about the barriers they create.

Reason · Jul 27, 2022

Halting backdoor government snooping seen as key to data privacy

Lawmakers say government purchases of data from private companies violates the Fourth Amendment and are looking to close the gap.

Roll Call · Jul 26, 2022

5 things to know about the FDA's flawed approach to accelerated drug approvals

An NPR investigation found stalled confirmatory trials and lax enforcement are plaguing the FDA's accelerated approval of drugs for urgent medical needs.

WEKU · Jul 25, 2022

Drugmakers are slow to prove medicines that got a fast track to market really work

Stalled confirmatory trials and lax enforcement plague the Food and Drug Administration's accelerated approval pathway for pharmaceuticals that target urgent medical needs.

WEKU · Jul 22, 2022

What's Going On With Tilray Stock As Cannabis Legalization Bill Reaches Senate?

Tilray Brands, Inc (NASDAQ: TLRY) gapped up about 4.5% higher on Thursday on news that the Cannabis Administration And Opportunity Act (CAOA) has been introduced in the U.S. Senate.

Benzinga · Jul 21, 2022

BREAKING: Schumer, Booker And Wyden Unveil Cannabis Legalization Bill - Here's What's In It

A long-awaited U.S. Senate legislation that would decriminalize and deschedule cannabis on the federal level, while also promoting social equity, has finally been unveiled.

Benzinga · Jul 21, 2022